S. Giard

发表

Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.

J. Bonneterre, T. Lacornerie, E. Lartigau, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial

F. Guillemin, A. Kramar, M. Chauvet, 2016, Journal of surgical oncology.

Real-Time Reverse-Transcription PCR to Quantify a Panel of 19 Genes in Breast Cancer: Relationships with Sentinel Lymph Node Invasion

F. Révillion, V. Lhotellier, L. Hornez, 2008, The International journal of biological markers.

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case‐control study

C. Granon, L. Mauriac, F. Chauvin, 1998, International journal of cancer.

Endometrial carcinoma associated with adjuvant tamoxifen therapy for breast cancer: a French multi-centre analysis of 89 cases

P. Rouanet, J. Rodier, É. Fondrinier, 1995 .

Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer.

C. Fournier, Y. Robin, M. Baranzelli, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.

G. MacGrogan, S. Mathoulin-Pélissier, L. Mauriac, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.

F. Révillion, V. Lhotellier, L. Hornez, 2008, The International journal of biological markers.

Endometrial carcinoma (EC) in women with breast cancer (BC)

C. Granon, L. Mauriac, F. Chauvin, 1997 .

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.

B. Esterni, P. Rouanet, P. Bonnier, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MammoSite].

E. Lartigau, Y. Belkacemi, F. Bonodeau, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

R. Gilles, M. Dilhuydy, L. Mauriac, 2003, British Journal of Cancer.

[Treatment of intraductal carcinomas. 91 cases treated at Oscar-Lambret Center].

S. Giard, J. Laurent, M. F. Patry-Lubeth, 1995, Journal de gynecologie, obstetrique et biologie de la reproduction.

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience

F. Penault-Llorca, H. Marsiglia, A. Fourquet, 2009, British Journal of Cancer.

Ductal carcinoma in situ (DCIS) of the breast: what is the safest treatment?

P. Quétin, C. Lemanski, C. Charra-Brunaud, 2003 .

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

J. Reis-Filho, L. Norton, A. Vincent-Salomon, 2015, Genome Biology.

Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients.

F. Penault-Llorca, C. Charra-Brunaud, H. Mignotte, 2001, European journal of cancer.

Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts

P. Gimbergues, D. Hudry, G. Houvenaeghel, 2014, BMC Cancer.

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model

R. Rouzier, P. Gimbergues, C. Mazouni, 2019, BMC Cancer.

Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study.

C. Sagan, G. Body, L. Campion, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

R. Rouzier, F. Reyal, P. Gimbergues, 2016, British Journal of Cancer.

Pure tubular carcinoma of the breast and sentinel lymph node biopsy: a retrospective multi-institutional study of 234 cases.

J. Rodier, C. Sagan, G. Ferron, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.

C. Ngô, P. Bonnier, C. Nos, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.

F. Bertucci, P. Colombo, F. Reyal, 2017, European journal of cancer.

Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.

B. Esterni, D. Hudry, G. Houvenaeghel, 2014, Breast.

Messenger RNA Expression of Leptin and Leptin Receptors and their Prognostic Value in 322 Human Primary Breast Cancers

F. Révillion, V. Lhotellier, L. Hornez, 2006, Clinical Cancer Research.

Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey

R. Rouzier, P. Rouanet, P. Bonnier, 2015, Annals of Surgical Oncology.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

C. Lemanski, C. Charra-Brunaud, H. Mignotte, 2002, International journal of radiation oncology, biology, physics.

Carcinoma mamario in situ

S. Giard, 2001 .

Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.

P. Rouanet, V. Bardou, C. Nos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nipple sparing mastectomy for breast cancer is associated with high patient satisfaction and safe oncological outcomes.

P. Collinet, C. Régis, E. Tresch, 2017, Journal of gynecology obstetrics and human reproduction.

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

E. Darai, F. Bertucci, R. Rouzier, 2017, Breast Cancer Research and Treatment.

[Ductal carcinoma in situ of the breast. Analysis of 882 cases].

C. Charra-Brunaud, H. Mignotte, B. Cutuli, 2004, Presse medicale.

Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.

C. Lemanski, É. Fondrinier, C. Charra-Brunaud, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.

Thomas Bachelot, Thierry Petit, Pierre Kerbrat, 2014, The Lancet. Oncology.

Breast cancer in young women: Pathologic features and molecular phenotype.

R. Rouzier, F. Reyal, C. Coutant, 2016, Breast.

Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo‐adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution

J. Bonneterre, L. Vanlemmens, Y. Robin, 2010, The breast journal.

Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.

B. Esterni, F. Penault-Llorca, C. Coutant, 2014 .

Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study.

C. Ngô, G. Ferron, G. Houvenaeghel, 2016, Breast.

Survival impact and predictive factors of axillary recurrence after sentinel biopsy.

R. Rouzier, P. Gimbergues, D. Hudry, 2016, European journal of cancer.

Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.

C. Lemanski, É. Fondrinier, C. Charra-Brunaud, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

B. Esterni, A. Agostini, F. Penault-Llorca, 2012, Breast.

Is adjuvant chemotherapy useful in lobular breast cancer patients?

N. Penel, X. Liem, M. Baranzelli, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).

P. Gimbergues, N. Penel, É. Fondrinier, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Sentinel Node Procedure is Warranted in Ductal Carcinoma In Situ with High Risk of Occult Invasive Carcinoma and Microinvasive Carcinoma Treated by Mastectomy

G. Houvenaeghel, J. Classe, M. Buttarelli, 2008, The breast journal.

Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.

B. Esterni, F. Penault-Llorca, C. Coutant, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].

J. Bonneterre, C. Fournier, Y. Belkacemi, 2005, Gynécologie Obstétrique & Fertilité.

[Intraoperative molecular assessment of sentinel nodes in the breast cancer using the Gene Search BLN Assay technique: our experience about 126 patients].

J. Bonneterre, Y. Robin, M. Vilain, 2011, Journal de gynecologie, obstetrique et biologie de la reproduction.

PP-2-8 Axillary lymphadenectomy prepared by fat aspiration versus functional axillary lymphadenectomy (fal): Preliminary results of a prospective randomized trial

S. Giard, J. Laurent, A. Dron, 1996 .

Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival

P. Gimbergues, D. Hudry, C. T. de Lara, 2016, BMC Surgery.

Sentinel lymph node biopsy validation for large tumors.

E. Darai, F. Reyal, P. Gimbergues, 2017, International journal of surgery.

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model

R. Rouzier, P. Gimbergues, C. Mazouni, 2019, BMC Cancer.

Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).

R. Rouzier, P. Colombo, F. Reyal, 2017, Breast.

Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.

R. Rouzier, F. Reyal, P. Gimbergues, 2016, European journal of cancer.

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'.

P. Colombo, P. Rouanet, P. Gimbergues, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Anne Vincent-Salomon, Salvatore Piscuoglio, Magali Lacroix-Triki, 2015, Genome Biology.

Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.

G. MacGrogan, L. Mauriac, M. Debled, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.